These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 10577673)

  • 21. CTLA-4 gene polymorphism in Japanese patients with rheumatoid arthritis.
    Yanagawa T; Gomi K; Nakao EI; Inada S
    J Rheumatol; 2000 Dec; 27(12):2740-2. PubMed ID: 11128657
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The CTLA4 region as a general autoimmunity factor: an extended pedigree provides evidence for synergy with the HLA locus in the etiology of type 1 diabetes mellitus, Hashimoto's thyroiditis and Graves' disease.
    Einarsdottir E; Söderström I; Löfgren-Burström A; Haraldsson S; Nilsson-Ardnor S; Penha-Goncalves C; Lind L; Holmgren G; Holmberg M; Asplund K; Holmberg D
    Eur J Hum Genet; 2003 Jan; 11(1):81-4. PubMed ID: 12529710
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Analysis of the CTLA4 gene in Swedish coeliac disease patients.
    Popat S; Hearle N; Wixey J; Hogberg L; Bevan S; Lim W; Stenhammar L; Houlston RS
    Scand J Gastroenterol; 2002 Jan; 37(1):28-31. PubMed ID: 11843030
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genetic markers in diagnosis and prediction of relapse in Graves' disease.
    Badenhoop K; Donner H; Braun J; Siegmund T; Rau H; Usadel KH
    Exp Clin Endocrinol Diabetes; 1996; 104 Suppl 4():98-100. PubMed ID: 8981012
    [TBL] [Abstract][Full Text] [Related]  

  • 25. No major role for the CTLA-4 gene in the association of autoimmune thyroid disease with IDDM.
    Djilali-Saiah I; Larger E; Harfouch-Hammoud E; Timsit J; Clerc J; Bertin E; Assan R; Boitard C; Bach JF; Caillat-Zucman S
    Diabetes; 1998 Jan; 47(1):125-7. PubMed ID: 9421385
    [No Abstract]   [Full Text] [Related]  

  • 26. CTLA-4 gene A-G polymorphism and childhood Graves' disease.
    Yung E; Cheng PS; Fok TF; Wong GW
    Clin Endocrinol (Oxf); 2002 May; 56(5):649-53. PubMed ID: 12030917
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CTLA-4 gene polymorphism and its association with Graves' disease in the Lebanese population.
    Nakkash-Chmaisse H; Makki RF; Abdelhamid E; Fakhoury H; Salti NN; Salti I
    Eur J Immunogenet; 2004 Jun; 31(3):141-3. PubMed ID: 15182328
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Advances in the genetics and immunology of autoimmune polyglandular syndrome II/III and their clinical applications.
    Muir A; She JX
    Ann Med Interne (Paris); 1999 Jun; 150(4):301-12. PubMed ID: 10519018
    [No Abstract]   [Full Text] [Related]  

  • 29. Association of Graves' disease and Graves' ophthalmopathy with the polymorphisms in promoter and exon 1 of cytotoxic T lymphocyte associated antigen-4 gene.
    Zhang Q; Yang YM; Lv XY
    J Zhejiang Univ Sci B; 2006 Nov; 7(11):887-91. PubMed ID: 17048303
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Polymorphism of CTLA-4 gene at position 49 of exon 1 may be associated with schizophrenia in the Korean population.
    Jun TY; Pae CU; Chae JH; Bahk WM; Kim KS; Han H
    Psychiatry Res; 2002 May; 110(1):19-25. PubMed ID: 12007590
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evidence for a Graves' disease susceptibility locus at chromosome Xp11 in a United Kingdom population.
    Imrie H; Vaidya B; Perros P; Kelly WF; Toft AD; Young ET; Kendall-Taylor P; Pearce SH
    J Clin Endocrinol Metab; 2001 Feb; 86(2):626-30. PubMed ID: 11158020
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Unraveling the genetic susceptibility to autoimmune thyroid diseases: CTLA-4 takes the stage.
    Tomer Y
    Thyroid; 2001 Feb; 11(2):167-9. PubMed ID: 11288987
    [No Abstract]   [Full Text] [Related]  

  • 33. CTLA-4 AT-repeat polymorphism reduces the inhibitory function of CTLA-4 in Graves' disease.
    Takara M; Kouki T; DeGroot LJ
    Thyroid; 2003 Dec; 13(12):1083-9. PubMed ID: 14751028
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Autoimmune thyroid disease genes come in many styles and colors.
    Davies TF
    J Clin Endocrinol Metab; 1998 Oct; 83(10):3391-3. PubMed ID: 9768635
    [No Abstract]   [Full Text] [Related]  

  • 35. Autoimmunity in thyroid disease.
    Collins J; Gough S
    Eur J Nucl Med Mol Imaging; 2002 Aug; 29 Suppl 2():S417-24. PubMed ID: 12192541
    [TBL] [Abstract][Full Text] [Related]  

  • 36. No evidence to support CTLA-4 as a susceptibility gene in MS families: the Canadian Collaborative Study.
    Dyment DA; Steckley JL; Willer CJ; Armstrong H; Sadovnick AD; Risch N; Ebers GC
    J Neuroimmunol; 2002 Feb; 123(1-2):193-8. PubMed ID: 11880164
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The A-G polymorphism in exon 1 of the CTLA-4 gene is not associated with systemic lupus erythematosus.
    Heward J; Gordon C; Allahabadia A; Barnett AH; Franklyn JA; Gough SC
    Ann Rheum Dis; 1999 Mar; 58(3):193-5. PubMed ID: 10364920
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CTLA-4 promoter variants in patients with Graves' disease and Hashimoto's thyroiditis.
    Braun J; Donner H; Siegmund T; Walfish PG; Usadel KH; Badenhoop K
    Tissue Antigens; 1998 May; 51(5):563-6. PubMed ID: 9672157
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Susceptibility genes for the development of autoimmune thyroid disease].
    Shirasawa S
    Nihon Rinsho; 2006 Dec; 64(12):2208-14. PubMed ID: 17154080
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CTLA-4/CD28 gene region is associated with genetic susceptibility to coeliac disease in UK families.
    King AL; Moodie SJ; Fraser JS; Curtis D; Reid E; Dearlove AM; Ellis HJ; Ciclitira PJ
    J Med Genet; 2002 Jan; 39(1):51-4. PubMed ID: 11826026
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.